Evidence map›Paper›PMID 39771127›Full record

ArticleToxics2024

Neurotransmitter Metabolic Disturbance in Methamphetamine Abusers: Focus on Tryptophan and Tyrosine Metabolic Pathways.

Xi Wang, Weilan Wu, Jing Liu, Miaoyang Hu, Jie Cheng, Jianping Xiong, Xufeng Chen, Rong Gao, Jun Wang

Abstract read
In one paragraph

Article in Toxics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xi WangCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Weilan WuCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Jing LiuCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Miaoyang HuCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Jie ChengCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Jianping XiongCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Xufeng ChenDepartment of Emergency Medicine, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Rong GaoCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Jun WangCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China.

Funding

Major Projects of Natural Science Foundation in Jiangsu Higher Education Institutions of China 22KJA330001National Natural Science Foundation of China 82072159National Natural Science Foundation of China 82073584Young and Middle-aged Academic Leaders of "Blue Project" in Jiangsu Province 2022-29
6 · The paper itself

Abstract

Methamphetamine (METH) abuse disrupts the homeostasis of neurotransmitter (NT) metabolism, contributing to a wide range of neurological and psychological disorders. However, the specific effects of METH on NT metabolism, particularly for the tryptophan (TRP) and tyrosine (TYR) metabolic pathways, remain poorly understood. In this study, serum samples from 78 METH abusers and 79 healthy controls were analyzed using Ultra-High-Performance Liquid Chromatography with Tandem Mass Spectrometry (UHPLC-MS/MS). A total of 41 substances, primarily from the TRP and TYR metabolic pathways, were detected and subjected to multivariate analysis. Principal Component Analysis (PCA) and Partial Least Squares Discriminant Analysis (PLS-DA) revealed a significant separation of serum metabolites between METH abusers and controls, encompassing the disturbance of serotonergic, kynurenic, and microbial metabolism. In the serotonergic pathway, METH significantly reduced melatonin (MLT) levels and impaired the conversion of serotonin (5-HT) to N-acetylserotonin (NAS), a key precursor of MLT. In the kynurenic pathway, METH promoted a shift to the toxic metabolic pathway, evidenced by elevated levels of 3-hydroxykynurenine (3-HK) and quinolinic acid (QA). Furthermore, microbial metabolic pathway-related indole and its derivatives were markedly suppressed in METH abusers. Gender-specific differences were also observed, with NT metabolism in TRP and TYR pathways showing more pronounced alterations in male or female subgroups. Therefore, the current study provides a comprehensive overview of the disturbance in TRP- and TYR-associated NT metabolism caused by METH abuse and highlights NT metabolism as a promising therapeutic target for METH-induced neural and psychiatric disorders.

Indexed as

methamphetamineneurotransmitterstryptophan metabolismtyrosine metabolism

Identifiers

PMID39771127
PMCPMC11728700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.